Key result
TTVI emerges as a surgical alternative despite preliminary experience mostly limited to compassionate use.
Why the study?
Isolated tricuspid surgery has very high morbidity and mortality, leaving many patients untreated, and clinical efficacy data for percutaneous tricuspid valve treatments are limited.
This review summarizes the challenges and emerging technologies for transcatheter tricuspid valve interventions in patients with severe tricuspid regurgitation.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to technical hurdles in transcatheter tricuspid interventions; leaves open optimal device selection and trial endpoints.
Taramasso et al. (2017) conducted a review in Tricuspid regurgitation. Transcatheter tricuspid valve interventions (TTVI) was evaluated. Transcatheter tricuspid valve interventions are emerging as an alternative to surgery, though clinical experience remains preliminary and mostly limited to compassionate use in end-stage patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: